These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6517902)

  • 1. Carrageenin-induced thrombosis in the rat and mouse as a test model of substances influencing thrombosis.
    Bekemeier H; Hirschelmann R; Giessler AJ
    Biomed Biochim Acta; 1984; 43(8-9):S347-50. PubMed ID: 6517902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of eicosanoids in the kappa-carrageenin rat tail thrombosis.
    Bekemeier H; Hirschelmann R
    Biomed Biochim Acta; 1988; 47(10-11):S260-3. PubMed ID: 2470355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-inflammatory effects of ZLJ-6, a novel dual cyclooxygenase/5-lipoxygenase inhibitor.
    Li L; Ji H; Sheng L; Zhang Y; Lai Y; Chen X
    Eur J Pharmacol; 2009 Apr; 607(1-3):244-50. PubMed ID: 19243697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of propionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1) serotonin and K-carrageenin.
    Bertelli A; Giovannini L; Galmozzi G; Bertelli AA
    Drugs Exp Clin Res; 1993; 19(1):7-11. PubMed ID: 8223141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin and phenprocoumon inhibit kappa-carrageenin induced thrombosis in rats.
    Hirschelmann R; Bekemeier H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):379-82. PubMed ID: 2428713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrageenin-induced thrombosis in rats and mice: a model for testing antithrombotic substances?
    Bekemeier H; Hirschelmann R; Giessler AJ
    Agents Actions; 1985 Jul; 16(5):446-51. PubMed ID: 4050621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving frequency of thrombosis by altering blood flow in the carrageenan-induced rat tail thrombosis model.
    Hagimori M; Kamiya S; Yamaguchi Y; Arakawa M
    Pharmacol Res; 2009 Oct; 60(4):320-3. PubMed ID: 19394423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylactic and therapeutic application of anti-inflammatory agents on the test method of carrageenin paw edema in the rat (author's transl)].
    Militzer K; Hirche H
    Arzneimittelforschung; 1981; 31(1):26-32. PubMed ID: 7194089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potentiating effect of propionyl carnitine on prostacycline prevention of thrombosis induced by endothelin (ET-1) and K-carrageenin.
    Bertelli A; Bertelli AA; Giovannini L
    Drugs Exp Clin Res; 1994; 20(1):7-11. PubMed ID: 7924894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative research of thrombosis animal model induced byendotoxin in combination with carrageenan in different animals].
    Liang AH; Yu CA; Li CY; Xue BY; Wang JH; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2006 Jan; 31(1):57-61. PubMed ID: 16548172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological and ultrastructural changes of cardiomyocytes in experimental rats with tail thrombosis following subplantar application of carrageenin.
    Kod'ousek R; Jezdínský J; Krajcí D
    Med Princ Pract; 2007; 16(5):360-6. PubMed ID: 17709924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models.
    Furugohri T; Shiozaki Y; Muramatsu S; Honda Y; Matsumoto C; Isobe K; Sugiyama N
    Eur J Pharmacol; 2005 May; 514(1):35-42. PubMed ID: 15878322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis induced by endothelin (ET-1) and carrageenin in rats treated with indomethacin and propionyl carnitine.
    Bertelli A; Bertelli AA; Galmozzi G; Giovannini L; Mian M
    Drugs Exp Clin Res; 1993; 19(2):75-8. PubMed ID: 8223146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the action of antiphlogistics, anti-anaphylactics and antihistaminics in the carrageenin- & immunologically-induced inflammation model in the rat and in passive cutaneous anaphylaxis.
    Grupe R; Rösner G; Denk J; Göres E
    Agents Actions Suppl; 1982; 10():273-87. PubMed ID: 6126090
    [No Abstract]   [Full Text] [Related]  

  • 15. A new low molecular weight heparan sulphate antagonizes kappa-carrageenan-induced thrombosis in rats.
    Gervasi GB; Bartoli C; Carpita G
    Pharmacol Res; 1991 Jul; 24(1):59-63. PubMed ID: 1658763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of serotonin, serotonin antagonists, some vasoactive substances and temperature on carrageenin-induced tail thrombosis in rats and mice.
    Bekemeier H; Hirschelmann R
    Agents Actions; 1986 Aug; 18(5-6):581-5. PubMed ID: 3766313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible nitric oxide synthase and cyclooxygenase-2 participate in anti-inflammatory and analgesic effects of the natural marine compound lemnalol from Formosan soft coral Lemnalia cervicorni.
    Jean YH; Chen WF; Duh CY; Huang SY; Hsu CH; Lin CS; Sung CS; Chen IM; Wen ZH
    Eur J Pharmacol; 2008 Jan; 578(2-3):323-31. PubMed ID: 17916350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
    Lorrain J; Millet L; Lechaire I; Lochot S; Ferrari P; Visconte C; Sainte-Marie M; Lunven C; Berry CN; Schaeffer P; Herbert JM; O'Connor SE
    J Pharmacol Exp Ther; 2003 Feb; 304(2):567-74. PubMed ID: 12538808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.